ConductScience.org, home

Paper20006455

Efficacy and safety of lanthanoids as X-ray contrast agents.

Pietsch H and 7 others. Eur J Radiol, 2011. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Efficacy and safety of lanthanoids as X-ray contrast agents. Papers, record 20006455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20006455

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy and safety of lanthanoids as X-ray contrast agents.
PubMed
Journal
Eur J Radiol
PubMed
Year
2011
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.67
iCite
Revised in PubMed
2014-11-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pietsch HHubertus
2Jost GGregor
3Frenzel TThomas
4Raschke MMarian
5Walter JJakob
6Schirmer HHeiko
7Hütter JJoachim
8Sieber MAMartin A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Contrast MediaMajor topic
Lanthanoid Series ElementsMajor topic
Nephrogenic Fibrosing DermopathyMajor topic
Skin DiseasesMajor topic
Tomography, X-Ray ComputedMajor topic
Animals
Biopsy
Blood Chemical Analysis
Chromatography, High Pressure Liquid
Cytokines
Gadolinium DTPA
Iohexol
Rats
Rats, Wistar

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
36770462Microfluidic Fabrication of Gadolinium-Doped Hydroxyapatite for Theragnostic Applications.Nanomaterials (Basel)2023https://conductscience.org/library/papers/36770462PubMed
34031377Versatile non-luminescent color palette based on guest exchange dynamics in paramagnetic cavitands.Nat Commun2021https://conductscience.org/library/papers/34031377PubMed
32390070Feasibility of CT quantification of intratumoural 166Ho-microspheres.Eur Radiol Exp2020https://conductscience.org/library/papers/32390070PubMed
29991152Analytical expressions for the reconstructed image of a homogeneous cylindrical sample exhibiting a beam hardening artifact in X-ray computed tomography.J Xray Sci Technol2018https://conductscience.org/library/papers/29991152PubMed
27620496Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.Adv Drug Deliv Rev2017https://conductscience.org/library/papers/27620496PubMed
25756684
Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study.
Invest Radiol2015https://conductscience.org/library/papers/25756684PubMed
20714270Fibroblast response to gadolinium: role for platelet-derived growth factor receptor.Invest Radiol2010https://conductscience.org/library/papers/20714270PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20006455

GET https://conductscience.org/api/papers/v1/20006455/authors